Results 141 to 150 of about 7,843 (191)

Causal Inference of Adverse Drug Events in Pulmonary Arterial Hypertension: A Pharmacovigilance Study. [PDF]

Pharmaceuticals (Basel)
Li H, He X, Chen C, Ni Q, Ni L, Zhou J, Peng B.   +6 more
europepmc   +1 more source

Treatment recommendations for the systemic pharmacological treatment of systemic sclerosis digital ulcers: Results from the World Scleroderma Foundation Ad Hoc Committee. [PDF]

J Scleroderma Relat Disord
Maltez N, Ross L, Baron M, Alunno A, Campochiaro C, Suliman YA, Schoones JW, Allanore Y, Del Galdo F, Denton CP, Distler O, Frech T, Furst DE, Giuggioli D, Khanna D, Khanna D, Krieg T, Kuwana M, Matucci-Cerinic M, Moinzadeh P, Pope J, Chung L, Hughes M.   +22 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Iloprost in dermatology

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2010
SummaryRheologically active pharmacotherapy is of high importance in many dermato‐logical diseases. The intravenous administration of iloprost belongs to the most effective systemic therapeutic agents that serve this pharmacodynamic approach and additionally substantial knowledge on the safety and efficacy exists.
Johannes, Wohlrab, Stefan, Schanz, Jens, Ulrich   +2 more
openaire   +2 more sources

Iloprost for Scleroderma

Annals of Internal Medicine, 1991
To the Editors: Iloprost (Schering Corporation, Kenilworth, New Jersey), a stable prostacyclin analog, is a powerful vasodilator and platelet anti-aggregant.
T, Constans, E, Diot, G, Lasfargues
openaire   +2 more sources

Iloprost

Reactions Weekly, 2015
  +6 more sources

Iloprost in pulmonary hypertension

Expert Review of Respiratory Medicine, 2008
Pulmonary hypertension is a clinically relevant, life-threatening disease. Based pathophysiologically on a dysbalance of vasoactive mechanisms, the therapeutic use of vasodilative agents is one of the major treatment options. Prostanoids, such as iloprost, are widely used in the treatment of patients with pulmonary hypertension.
Ralf, Ewert, Sven, Gläser, Christian, Opitz   +2 more
openaire   +2 more sources

Iloprost in Prinzmetal's angina

The American Journal of Cardiology, 1986
Abstract Prostacyclin, the main product of arachidonic acid metabolism in the vessel wall, combines powerful vasodilatory, antiaggregatory and cytoprotective effects, all of which may be useful in treating myocardial ischemia. Studies of the use of prostacyclin in vasospastic angina have produced conflicting results.
DE CATERINA, Raffaele, Pelosi G, Carpeggiani C, Bernini W, Giannessi D, Lazzerini G, L'Abbate A.   +6 more
openaire   +4 more sources